The chief significance of the data mining that worries the legislators in Vermont is precisely that it can give valuable information to these detailers, helping to further entrench brand-name drugs as part of the medical scene in Vermont, keeping generics (they fear) on the margins of the markets.

FORBES: Supreme Court Helps Big Pharma Stay Fat And Happy In Sorrell Ruling